Literature DB >> 3891652

Oncogenic transformation with radiation and chemicals.

E J Hall, T K Hei.   

Abstract

Quantitative in vitro assay systems for oncogenic transformation are a powerful research tool. They may be based on short-term cultures of hamster embryo cells, or established cell lines of mouse origin. While X-ray-induced transformation of human cells has been demonstrated, it has proved difficult to develop quantitative assay systems based on cells of human origin. The presently available quantitative assays have two quite distinct basic uses. First, they may be useful to accumulate data which is essentially pragmatic in nature. For example, they may be used to compare and contrast the oncogenic potential of chemotherapeutic agents or hypoxic cell sensitizers used or proposed in the clinic. They may be used to identify compounds that inhibit or suppress the transformation incidence resulting from known oncogenic agents, or they may be used to demonstrate the interaction between two different agents, such as radiation and asbestos. Second, they may prove to be invaluable in the study of the basic mechanisms of carcinogenesis, inasmuch as they represent models of tumourigenesis in which the various steps can be manipulated and modified more readily and in a controlled way.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891652     DOI: 10.1080/09553008514551021

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  3 in total

1.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

2.  Antibodies against free radical modified DNA in cancer patients.

Authors:  A D Deepak; S A Siddiqui; A Ali
Journal:  Indian J Clin Biochem       Date:  2000-08

3.  The oncogenic potential of a combination of hyperthermia and chemotherapy agents.

Authors:  K Komatsu; R C Miller; E J Hall
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.